Mark Tullman, MD Joins Our Center

Aug 1 2011

Mark Tullman, MD joined The MS Center for Innovations in Care on the campus of Missouri Baptist Medical Center on July 29, 2011.  A native of St. Louis, Dr. Tullman was formerly director of the Multiple Sclerosis Clinical Care Center for the Neurological Institute of New York at Columbia University Medical Center, New York. Prior to this, he was assistant professor of neurology at Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai School of Medicine, New York.

After earning his medical degree from the University of Missouri-Columbia, he completed his residency in internal medicine at Albert Einstein College of Medicine, Bronx, New York. He completed his neurology residency and a postdoctoral fellowship in multiple sclerosis at Mount Sinai School of Medicine, New York.

Board-certified in neurology, he specializes in all aspects of MS patient care, including treatment with the disease-modifying drugs and symptomatic therapies. He has been principal investigator for numerous MS clinical trials and has published a variety of MS-related articles and book chapters.
Dr. Tullman’s dedication to the field of MS was recognized when he was honored with the Sylvia Lawry Physician Fellowship award from the National Multiple Sclerosis Society and with the Martin S. Davis Multiple Sclerosis Fellow by the New York City Chapter of the National Multiple Sclerosis Society.

In addition to his memberships in the American Medical Association and the American Academy of Neurology, Dr. Tullman serves on the Board of Directors of MS Hope for a Cure and the editorial board of Continuum, the continuing medical education publication of the American Academy of Neurology.

“I am extremely pleased to have Dr. Mark Tullman, a national leader in multiple sclerosis, joining our Center,” stated Barry Singer, MD, director, and a recognized leader in MS care. “Dr. Tullman will help us to broaden our ability to provide comprehensive, forward-thinking care to more multiple sclerosis patients throughout the region and beyond.”

BY: Barry Singer, MD DATE: August 1, 2011 TOPIC: MS Center News